Acute kidney injury in ICU & RRT timing
AKI / RRT · Critical Care / ICU
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
AKI is common in critical illness and defined by KDIGO criteria using rises in creatinine and falls in urine output. Management focuses on treating the cause, optimising perfusion, avoiding nephrotoxins, and timing renal replacement therapy by clinical need rather than an absolute threshold.
Red flags
- Refractory hyperkalaemia with ECG changes
- Severe metabolic acidosis pH below 7.15
- Diuretic-resistant pulmonary oedema
- Uraemic pericarditis or encephalopathy
- Anuria
Assessment
Differential diagnosis
- Sepsis-associated AKI
- Hypovolaemia / pre-renal
- Nephrotoxic drug injury
- Cardiorenal / congestive
- Abdominal compartment syndrome
- Rhabdomyolysis
- Obstructive uropathy
Investigations
- Serial creatinine and urine output (KDIGO staging)
- Urinalysis and urine microscopy
- Renal tract ultrasound to exclude obstruction
- Serum potassium, bicarbonate, pH
- Creatine kinase if rhabdomyolysis suspected
- Fluid-responsiveness and bladder pressure assessment
Management
- Stage AKI by KDIGO: stage 3 is creatinine 3x baseline, or above 354 micromol/L, or anuria 12 h / oliguria 24 h, or on RRT
- Identify and treat the cause: resuscitate shock, treat sepsis, relieve obstruction, stop nephrotoxins
- Optimise perfusion with fluid responsiveness-guided resuscitation and vasopressors to a MAP usually 65 mmHg (higher if chronic hypertension)
- Stop or dose-adjust nephrotoxic drugs (NSAIDs, aminoglycosides, contrast) and review ACE inhibitors/ARBs
- Manage hyperkalaemia, acidosis and fluid overload medically first
- Avoid starting RRT for isolated biochemical numbers if no emergency indication
- Start RRT urgently for refractory hyperkalaemia, severe acidosis, diuretic-resistant fluid overload, or uraemic complications
- Choose CRRT for haemodynamic instability or raised ICP; intermittent HD if stable
- Set RRT dose to around 20-25 mL/kg/h effluent for CRRT and avoid excessive dosing
- Monitor and avoid hypophosphataemia and circuit-related hypothermia
- Reassess daily for renal recovery and RRT weaning
Drugs & doses
Balanced crystalloid guided by fluid responsiveness
Noradrenaline 0.05-0.5 mcg/kg/min IV to maintain MAP
Furosemide 40-80 mg IV (for fluid overload, not to treat AKI itself)
Calcium gluconate 10% 10-30 mL IV for hyperkalaemic cardioprotection
Disposition
ICU with nephrology liaison; CRRT for unstable patients. Document ceiling of care and renal recovery expectations.
Complications & pitfalls
- Hyperkalaemic cardiac arrest
- Fluid overload / pulmonary oedema
- Progression to chronic kidney disease
- Dialysis disequilibrium
- Bleeding from anticoagulated circuit
Exam pearls
- Early vs delayed RRT showed no survival benefit when the delayed arm started on clear indications - start RRT for need, not numbers
- Do not use loop diuretics or dopamine to prevent or treat AKI
- Choose CRRT over intermittent HD in shock and in acute brain injury
- Target MAP higher (80-85) in chronically hypertensive septic patients to protect kidneys
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.